Dosidal · Switzerland

Ruxience, Konzentrat zur Herstellung einer Infusionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:69701 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 69701
atc: L01FA01
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2024-08-19
term: zugelassen
valid_until: 2029-08-18
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: L01FA01
authorisation_number: 69701
form: KOINF
holder: Pfizer AG
holder_partner_nr: 1001107
it_number: 07.16.1.
name: Ruxience, Konzentrat zur Herstellung einer Infusionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
2Ls8ajziS5F0gyMBADTFjunCfw4Eyzv7_ZLYZ-N5tgqBylKmdAgtcA02ojEGCMxGd7QADoryNZsjb2i_xMELyQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:69701 · Related records in other markets · Dosidal